Landfar Bio-medicine Co., Ltd (SHE:000504)

Market Cap	3.35B +7.5%
Revenue (ttm)	125.47M +0.8%
Net Income	-6.20M
EPS	-0.02
Shares Out	330.02M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,711,000
Average Volume	4,117,755
Open	10.01
Previous Close	10.07
Day's Range	9.97 - 10.31
52-Week Range	5.43 - 12.54
Beta	0.73
RSI	60.26
Earnings Date	Apr 29, 2026

About Landfar Bio-medicine

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment engages in the provision of stem cell, immune cell storage and technical services, and medical device trade. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was founded in 1...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 378
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000504

Financial Performance

In 2024, Landfar Bio-medicine's revenue was 134.45 million, a decrease of -1.71% compared to the previous year's 136.79 million. Losses were -19.85 million, -29.56% less than in 2023.